| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 唐寅灏 | 中信证券 | 医药生物 | 34.57% | 30.25% | 28.18% | 60.00% | 12 | -8.47% | 2025-05-22 |
| 2 | 张林晚 | 上海证券 | 医药生物 | 34.51% | 39.18% | 27.60% | -100.00% | 1 | -18.93% | 2025-07-23 |
| 3 | 年庆功 | 国海证券 | 医药生物 | 34.41% | 36.60% | 29.84% | -33.33% | 5 | -18.14% | 2025-07-31 |
| 4 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 34.37% | 44.22% | 38.73% | 3.45% | 2 | -27.10% | 2025-04-16 |
| 5 | 吴春红 | 江海证券 | 医药生物 | 34.33% | 35.92% | 8.79% | 27.27% | 5 | -25.67% | 2025-08-01 |
| 6 | 武煜 | 招银国际 | 医药生物 | 34.26% | 28.43% | 21.54% | 0.00% | 2 | -6.92% | 2025-06-03 |
| 7 | 李安飞 | 广发证券 | 医药生物 | 34.19% | 21.66% | 36.42% | 2.86% | 1 | -56.96% | 2025-04-03 |
| 8 | 吴春红 | 江海证券 | 医药生物 | 34.16% | 17.40% | 17.33% | 27.27% | 7 | -25.67% | 2025-06-12 |
| 9 | 仰佳佳 | 申万宏源 | 医药生物 | 34.04% | 34.04% | 9.25% | 16.67% | 1 | -37.64% | 2025-07-01 |
| 10 | 张林晚 | 上海证券 | 医药生物 | 34.03% | 38.15% | 35.55% | -100.00% | 1 | -18.93% | 2025-07-09 |
| 11 | 王斌 | 首创证券 | 医药生物 | 34.00% | 38.06% | 20.82% | -3.03% | 19 | -54.62% | 2025-07-22 |
| 12 | 任晓帆 | 东海证券 | 医药生物 | 33.96% | 31.86% | 37.14% | 0.00% | 2 | -17.50% | 2025-07-25 |
| 13 | 仰佳佳 | 申万宏源 | 医药生物 | 33.95% | 33.85% | -3.58% | 16.67% | 1 | -37.64% | 2025-07-30 |
| 14 | 华挺 | 财通证券 | 医药生物 | 33.95% | 34.50% | 9.77% | -6.67% | 7 | -50.33% | 2025-07-14 |
| 15 | 吴春红 | 江海证券 | 医药生物 | 33.89% | 19.97% | 26.54% | 27.27% | 7 | -25.67% | 2025-05-20 |
| 16 | 刘浩 | 华创证券 | 医药生物 | 33.86% | 32.06% | 32.51% | 20.00% | 2 | -47.33% | 2025-04-24 |
| 17 | 吴春红 | 江海证券 | 医药生物 | 33.84% | 15.03% | 22.86% | 27.27% | 7 | -25.67% | 2025-06-03 |
| 18 | 阳景 | 浦银国际证券 | 医药生物 | 33.84% | 27.07% | 13.99% | 100.00% | 4 | 0.00% | 2025-06-10 |
| 19 | 李安飞 | 广发证券 | 医药生物 | 33.82% | 21.33% | 33.82% | 2.86% | 1 | -56.96% | 2025-04-01 |
| 20 | 阳景 | 浦银国际证券 | 医药生物 | 33.80% | 33.80% | 1.53% | 100.00% | 4 | 0.00% | 2025-07-01 |